coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Pendle West PCN, Pendle · Health Inequalities Profile

    PCN U08086 · NHS Lancashire and South Cumbria Integrated Care Board · 6 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    51,614

    Registered population

    58.9% aged 18–64

    14.7%

    Aged 65+

    ICB 20.0% · England 17.9%

    45.2%

    Ethnic minority (non-White)

    41.9% Asian · England 9.6%

    65.4%

    In IMD quintile 1

    ICB 30.6% · England 21.0%

    ~31,341

    Core20 residents (est.)

    Resident basis; registered basis ~34,738 · see page 3

    7,027

    Hypertension register

    +2.56% in 3 yrs · England +5.60%

    582

    SMI register

    51.5% of Pendle's

    935

    COPD register

    Reviews +3.90% in 3 yrs

    Forecast to 2030

    7,493

    Hypertension patients, 2030

    +466 on today

    100.0%

    QRISK ≥20% on statins, 2030

    +12.02pp over 3 yrs

    3.0%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    63.5%
    Under-80 blood pressure and diabetes control lag.

    Under-80 hypertension control is 63.5% (England 67.8%) after a -2.4% three-year change (England +3.2%), while non-frail diabetes HbA1c control is 49.1% (England 57.4%).

    72.8%
    Lipid-lowering therapy exceeds benchmarks at lower unit cost.

    Patients with QRISK >= 20% on lipid-lowering therapy reached 72.8% (Pendle 66.2%, ICB 61.4%, England 63.6%) after +19.8% growth, costing £1.40 per item.

    52.8%
    Preventive screening, immunisation and asthma review shortfalls.

    Cervical screening aged 25-49 is 52.8% (England 66.8%), age-5 MMR2 is 80.9% against the 95.0% target, and an estimated 1,369 asthma patients lack reviews.

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    A young population with 26.3% children and 41.9% Asian residents may shape local need

    Across 51,614 registered patients, 26.3% are aged 0-17, exceeding Pendle (22.8%), the ICB (19.6%), and England (19.6%), whereas 14.7% are aged 65+, trailing Pendle (17.0%), the ICB (20.0%), and England (17.9%). In associated Census areas, 41.9% of residents are Asian or Asian British, compared with 26.7% in Pendle, 9.4% in the ICB, and 9.6% in England. This younger age structure may elevate paediatric demand while moderating crude older-age disease prevalence. Note that Census resident ethnicity reflects local catchment areas rather than confirmed practice registrations.

    Age profile

    0–1726.3%
    18–6458.9%
    65+14.7%

    65+: ICB 20.0%, England 17.9%

    Ethnicity

    White54.8%
    Asian41.9%
    Mixed1.8%
    Other1.3%
    Black0.3%

    Older people · falls rows are Pendle local-authority (LA) data, not PCN

    MeasureLocalNorth WestEnglandPeriod
    Falls admissions, 65+, per 100,000 (Pendle LA)1,4612,0711,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)81.7%82.9%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)49.1%56.6%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Pendle LA)7121,0219552024/25
    Falls deaths, all ages, per 100,000 (Pendle LA)13.618.214.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 deprivation reaches 65.4% PCN-wide, spanning 32.0 pp across practices

    Across Pendle West PCN, 65.4% of registered patients live in Core20 areas (Pendle 46.6%, ICB 30.6%, England 21.0%), with an average IMD decile of 2.3 (Pendle 3.5, ICB 5.0, England 5.5). The practice-weighted Core20 share is 67.3%, showing a 1.94 percentage point discrepancy against the PCN figure. Practice concentration spans 32.0 pp from Reedyford Hlth Care Group (53.0%) to Whitefield Healthcare (85.0%), while volume concentrates at Nelson Medical Practice (9,118 estimated patients). Targeting both concentration and volume avoids under-serving large deprived cohorts.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Whitefield85.0% · 3,356 patients
    Nelson Medical84.0% · 9,118 patients
    Dr Jehangir (sh)78.4% · 1,966 patients
    Pwe Pendle Valley67.2% · 7,853 patients
    Pendle View58.5% · 4,841 patients
    Reedyford Hlth53.0% · 7,604 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    582

    SMI register

    1.09% recorded prevalence

    357

    Learning disability register

    0.67% recorded prevalence

    13

    Care homes, 424 beds

    In the PCN catchment

    9.5%

    Provide unpaid care

    Pendle, Census 2021

    The PCN records 357 patients on the learning disability register (0.7% versus 0.5% in Pendle, 0.6% in the ICB, and 0.6% in England) and 582 with severe mental illness (1.1% versus 1.1% in Pendle and 1.0% in England), alongside 424 care-home beds across 13 homes. Catchment bed counts do not confirm registered PCN patients.

    Severe mental illness: physical health checks

    SMI physical health checks trail England for blood pressure (76.8% versus 83.4%), BMI (73.4% versus 82.1%) and psychosis alcohol recording (67.9% versus 81.8%). Routine monitoring shortfalls indicate an opportunity to systematise annual physical health check recall.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    7,027

    Hypertension register

    +2.56%

    Register growth, 3 yrs

    Pendle +3.69% · England +5.60%

    −1.56pp

    BP control, under 80

    ≤140/90 · −0.52pp aged 80+

    +466

    More patients by 2030

    Forecast 7,493 (13.84%)

    Hypertension case-finding and control

    Recorded hypertension prevalence is 13.2% (7,027 patients), below Pendle (14.9%), the ICB (17.2%) and England (15.2%), while three-year register growth of +2.6% trails England (+5.6%). Blood pressure control in patients aged under 80 is 63.5%, behind England (67.8%) and the ICB (67.1%), with a three-year change of -2.4% (England +3.2%). Furthermore, hypertension treated to target is 67.5% (England 70.3%) following a -1.7% three-year change (England +3.6%). Denominators include personalised care adjustments, and observation periods for the register and list size are not confirmed to match. Trailing national blood pressure control benchmarks indicates that prioritising proactive clinical recall and treatment titration for under-80 hypertensive patients is an immediate operational need.

    Lipids and statins

    Patients with QRISK ≥ 20% on lipid-lowering therapy reached 72.8%, above Pendle (66.2%), the ICB (61.4%) and England (63.6%), following a +19.8% three-year change (England +6.2%). Higher lipid-lowering therapy coverage than England indicates strong primary prevention that the PCN should sustain across cardiovascular pathways.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202696,635£1.40£1.64£1.86£135,289
    Cardiovascular (all), 2025124,589£3.26£3.38£3.33£406,160

    In 2026, lipid-modifying drugs cost £1.40 per item across 96,635 items, below Pendle (£1.72), the ICB (£1.64) and England (£1.86), spending £44,452 less than at England's unit cost. Spending less per item on lipid-modifying drugs than England leaves financial scope to sustain wide treatment coverage while monitoring appropriate dosing.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +7.61%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    −0.46%

    Asthma prevalence, PCN 3-yr % change

    Asthma prevalence is 7.6% (England 6.6%), covering 3,756 patients, while 12-month reviews reached 63.5% (England 65.7%), leaving an estimated 1,369 patients unreviewed. Second-hand smoke recording in ages 6-19 is 67.5% (England 78.8%), and asthma management items prescribed per 1,000 aged 5-19 is 1,017 rate (England 1,488 rate). COPD prevalence is 1.8% (England 1.9%) with 77.0% reviewed (England 76.4%).

    Cancer register and children's immunisation

    Cancer prevalence is 2.7% (England 3.8%), with 1,431 registered patients. Childhood immunisations trail the 95.0% target: at 24 months, MMR1 is 77.1% (England 88.3%) and 6-in-1 is 81.4% (England 92.2%). At age 5, MMR2 is 80.9% (England 82.8%), trailing age-5 MMR1 (93.2%) by 12.3 pp.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months84.7%

    England 91.0%

    6-in-1 complete primary course at 24 months81.4%

    England 92.2%

    MMR dose 1 at 24 months77.1%

    England 88.3%

    MMR dose 2 at age 580.9%

    England 82.8%

    4-in-1 pre-school booster at age 577.8%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    52.4%

    Lancashire and South Cumbria ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~2,010

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Lancashire and South Cumbria ICBEnglandNo usable stageStaged cancers
    Breast86.0%85.4%6%1,561
    Prostate42.4%53.2%11%1,404
    Lung31.1%33.8%15%1,374
    Bowel44.2%47.0%13%1,198
    Skin cancer86.1%87.8%21%519

    In 2022, 52.4% of cancers with a known stage in NHS Lancashire and South Cumbria ICB (4,642 of 8,863) were diagnosed at stage 1 or 2, trailing England (55.3%) and 22.6 percentage points below the 75.0% national ambition by 2028. Staged data covered 74.6% of registered cancers (8,863 of 11,883). These system figures describe the ICB rather than PCN performance. At PCN level, cervical screening coverage in women aged 25-49 is 52.8% (England 66.8%), including 47.2% at Pwe Pendle Valley Mill, 47.9% at Dr Jehangir (sh), and 49.9% at Whitefield Healthcare; breast screening coverage is 63.3% (England 69.9%).

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In July 2026 (provisional), East Lancashire Hospitals NHS Trust achieved 81.5% on the cancer 28-day faster diagnosis standard, above the 75.0% standard, Northern Care Alliance NHS Foundation Trust (75.2%), the ICB (78.4%) and England (79.3%), but behind Airedale NHS Foundation Trust (87.7%). On the 62-day referral to treatment standard, the trust reached 73.2%, trailing the 85.0% standard, the ICB (73.6%), Northern Care Alliance NHS Foundation Trust (78.6%) and Airedale NHS Foundation Trust (88.9%). At month end, 0.4% waited 6+ weeks for MRI and 0.1% for CT, below England (21.4% and 9.9%).

    Pathways within standard (%)East LancashireAiredaleNorthern Care AllianceLancashire and South Cumbria ICBEngland
    28-day faster diagnosis (75%)81.5087.7175.2078.3979.32
    31-day treatment (96%)98.1198.2094.5493.6292.50
    62-day referral to treatment (85%)73.1688.8978.6573.6271.16
    Diagnostic waits over 6 weeks (%)East LancashireAiredaleNorthern Care AllianceEngland
    MRI0.432.915.0921.40
    CT0.150.004.109.92
    Echocardiography0.000.7031.4828.48
    Colonoscopy0.9531.2140.0430.83
    Gastroscopy1.1622.9836.4829.02
    All 15 DM01 tests3.254.3315.7123.14
    Community services activityLancashire residentsLancashire and South Cumbria ICB
    Care contacts126,445193,720
    Referrals20,41529,855
    Patients with a contact47,32065,335

    Community services (residents of Lancashire), Jun 2026 (provisional). In provisional June 2026 data, 56.9% of community service contacts for Pendle borough residents were for adults aged 65 and over (72,000 of 126,445 contacts). These figures describe borough-wide resident utilisation rather than PCN-level activity. This pattern is consistent with substantial older-age community health needs across the wider area, reinforcing the value of primary care alignment with community services.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Easy phone contact spans 43.9 percentage points across captured practices

    In 2025/26, QOF overall achievement ranged from 79.9% at Dr Jehangir (sh) to 90.9% at Whitefield Healthcare against England's 92.5%. Vaccination and immunisation achievement lagged England (55.2%) across captured practices, spanning 12.6 pp from 15.6% at Dr Jehangir (sh) to 28.2% at Nelson Medical Practice, while personalised care adjustment rates reached 16.2% at Pwe Pendle Valley Mill.

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Whitefield10585.063.7%69.3%79.9%
    Pendle View10158.563.4%81.3%79.3%
    Reedyford Hlth8253.058.3%75.0%77.0%
    Nelson Medical10184.030.0%75.3%65.1%
    Dr Jehangir (sh)9878.445.7%59.0%61.8%
    Pwe Pendle Valley11867.219.8%75.5%47.0%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNPendleAssetPCNPendle
    Care homes (catchment)13 (424 beds)n/aSchools (catchment)54n/a
    Children's centres47Places of worship4271
    Libraries48Primary schools (LA maintained)1522
    Primary academies89Special schools11

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Asthma review and smoke-recording recall

    Of 3,756 asthma patients (7.6% prevalence versus England 6.6%), 63.5% had a 12-month review (England 65.7%), leaving an estimated 1,369 unreviewed; 6-19 second-hand smoke recording is 67.5% (England 78.8%). Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 2

    Under-80 hypertension titration recall

    Across 7,027 hypertension patients (13.2% prevalence), under-80 BP control is 63.5% (England 67.8%, ICB 67.1%) after a -2.4% three-year change (England +3.2%); overall treatment to target is 67.5% (England 70.3%). Moderate effort to run.

    Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.

    Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).

    Option 3

    Combined SMI physical health checks

    Across the 582-patient SMI register, annual checks trail England for BP (76.8% versus 83.4%), BMI (73.4% versus 82.1%) and psychosis alcohol recording (67.9% versus 81.8%, falling 1.7 pp over three years). Moderate effort to run.

    Evidence base: the SMI register is the cohort for the annual physical health check; the alcohol record is the delivery measure for alcohol screening and brief intervention.

    Policy anchor: Mental Health Investment Standard; NHS alcohol care teams and the From Harm to Hope strategy.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Targeted multilingual access review (p2)Asian / Asian BritishNeighbourhood health framework · Core20PLUS5 approachPCN
    Dual-track Core20 outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    SMI physical health check outreach (p4)SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Hypertension treatment titration (p5)Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Paediatric immunisation recall campaign (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Cervical screening recall outreach (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Option 1 · Asthma review and smoke-recording recall (p12)Asthma register · Asthma: QOF prevalence · Patients with Asthma: review in the last 12 months (denominator incl. PCAs)Core20PLUS5 respiratoryPCN
    Option 2 · Under-80 hypertension titration recall (p12)Hypertension register · Hypertension: QOF prevalence · Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Option 3 · Combined SMI physical health checks (p12)Severe mental illness register · SMI register with a BP check in the last 12 months · SMI register with a BMI recorded in the last 12 monthsMHIS · From Harm to HopePCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026ICB2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15